<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2022.870805</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis <italic>via</italic> the Wnt/CaMKII Signaling Axis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Geng</surname><given-names>Bochao</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname><given-names>Yuanzhang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname><given-names>Yingying</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bai</surname><given-names>Jingyi</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dou</surname><given-names>Zhizhi</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sui</surname><given-names>Aihua</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Luo</surname><given-names>Wenjuan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1347270"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Ophthalmology, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Central Laboratory, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and reviewed by: Jill Kolesar, University of Kentucky, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Wenjuan Luo, <email xlink:href="mailto:luowenjuan@qduhospital.cn">luowenjuan@qduhospital.cn</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Oncology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>12</volume>
<elocation-id>870805</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>02</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Geng, Zhu, Yuan, Bai, Dou, Sui and Luo</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Geng, Zhu, Yuan, Bai, Dou, Sui and Luo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fonc.2021.714646" ext-link-type="doi">A Corrigendum on: <article-title>Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis <italic>via</italic> the Wnt/CaMKII Signaling Axis</article-title> By Geng B, Zhu Y, Yuan Y, Bai J, Dou Z, Sui A and Luo W (2021). Front. Oncol. 11:714646. doi:&#xa0;<object-id>10.3389/fonc.2021.714646</object-id>.</related-article>
<kwd-group>
<kwd>artesunate</kwd>
<kwd>choroidal melanoma</kwd>
<kwd>vasculogenesis mimicry</kwd>
<kwd>angiogenesis</kwd>
<kwd>VE-cadherin</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="231"/>
</counts>
</article-meta>
</front>
<body>
<p>In the original article, there was a mistake in <xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7</bold></xref> as published. We recognized by ourselves that the image of the Ctrl siRNA group in OCM-1 cells was misused. The corrected <xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7</bold></xref> appears below.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>ART interrupted VM formation in CM cells <italic>via</italic> Wnt5a/CaMKII pathway. OCM-1 and C918 cells transfected with Wnt5a siRNA or scrambled siRNA subsequently seeded on three-dimensional Matrigel layer culture for 24&#xa0;h. OCM-1 and C918 cells transfected with Wnt5a siRNA showed a decrease in the number of tubes formed compared with cells transfected with scramble siRNA. Compared with the cells transfected only with small interfering RNA, transfected cells treated with ART have an enhanced inhibitory effect on tube formation. The results are represented as the mean &#xb1; SEM of three independent samples. <sup>**</sup>P &lt; 0.01, <sup>***</sup>P &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-12-870805-g007.tif"/>
</fig>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
</article>